We assembled an ancestrally diverse collection of genome-wide association studies (GWAS)
of type 2 diabetes (T2D) in 180,834 affected individuals and 1,159,055 controls (48.9% non…

Common single-nucleotide polymorphisms (SNPs) are predicted to collectively explain 40–50%
of phenotypic variation in human height, but identifying the specific variants and …

Performing genetic studies in multiple human populations can identify disease risk alleles
that are common in one population but rare in others, with the potential to illuminate …

Glycemic traits are used to diagnose and monitor type 2 diabetes and cardiometabolic health.
To date, most genetic studies of glycemic traits have focused on individuals of European …

Importance Latino populations have one of the highest prevalences of type 2 diabetes worldwide.
Objectives To investigate the association between rare protein-coding genetic variants …

Genome-wide association studies (GWAS) have identified more than 80 susceptibility loci for
type 2 diabetes (T2D), but most of its heritability still remains to be elucidated. In this study, …

Type 2 diabetes (T2D) affects Latinos at twice the rate seen in populations of European
descent. We recently identified a risk haplotype spanning SLC16A11 that explains ∼20% of the …

Peroxisome proliferator-activated receptor gamma (PPARG) is a master transcriptional
regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione …

Several studies have identified nearly 40 different type 2 diabetes susceptibility loci, mainly
in European populations, but few of them have been evaluated in the Mexican population. …

Insulin sensitivity, insulin secretion, insulin clearance, and glucose effectiveness exhibit
strong genetic components, although few studies have examined their genetic architecture or …